XML 28 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]      
Revenue [1] $ 61 $ 130 $ 84,683
Operating expenses:      
Research and development 171,603 182,945 159,188
General and administrative 52,041 66,983 117,307
Other operating income, net (3,309) (2,790) (4,754)
Acquired in-process research and development 87,184 0 0
Impairment of long-lived assets 51,297 0 0
Total operating expenses 358,816 247,138 271,741
Loss from operations (358,755) (247,008) (187,058)
Interest income, net 24,068 23,453 7,053
Other income, net 4,694 1,846 1,887
Impairment of other investments (13,001) (12,923) (5,000)
Total other income, net 15,761 12,376 3,940
Net loss (342,994) (234,632) (183,118)
Other comprehensive loss:      
Net unrealized gain (loss) on marketable securities 385 7,505 (5,976)
Comprehensive loss $ (342,609) $ (227,127) $ (189,094)
Net loss per common share, basic (in dollars per share) $ (1.31) $ (0.93) $ (0.74)
Net loss per common share, diluted (in dollars per share) $ (1.31) $ (0.93) $ (0.74)
Weighted-average shares used to compute net loss per common share, basic (in shares) 261,480 250,983 247,080
Weighted-average shares used to compute net loss per common share, diluted (in shares) 261,480 250,983 247,080
[1] Includes related-party revenue of zero for both the years ended December 31, 2024 and 2023 and $84,653 for the year ended December 31, 2022.